stella
beta
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC — Stella
Recruiting
Back to Nasopharangeal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov